Efficacy and Safety of Darolutamide Combined With ADT in High-risk/Very High-risk Localized Prostate Cancer
Conditions
Interventions
- DRUG: Darolutamide 300 mg
- OTHER: Androgen deprivation therapy
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Collaborators
- [object Object]
- [object Object]